Distress reduction from a psychological intervention contributes to improved health for cancer patients

Brain, Behavior, and Immunity

Volumn 21, Issue 7, 2007, Pages 953-961

  Andersen, Barbara L ^a   Farrar, William B ^a   Golden Kreutz, Deanna ^a   Emery, Charles F ^a   Glaser, Ronald ^b   Crespin, Timothy ^a   Carson III, William E ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Biobehavioral; Breast cancer; Health; Immune; Psychological; Quality of life

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER THERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DISTRESS SYNDROME; EMOTIONAL STRESS; HEALTH STATUS; HUMAN; IMMUNITY; MAJOR CLINICAL STUDY; PERFORMANCE; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; PSYCHOLOGICAL WELL BEING; RANDOMIZED CONTROLLED TRIAL; REDUCTION; SOCIAL ASPECT; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY; TOXICITY; TREATMENT DURATION;

AFFECTIVE SYMPTOMS; BREAST NEOPLASMS; FEMALE; HEALTH STATUS; HUMANS; IMMUNE SYSTEM; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PSYCHONEUROIMMUNOLOGY; PSYCHOTHERAPY, GROUP; QUALITY OF LIFE; STRESS, PSYCHOLOGICAL; TREATMENT OUTCOME;

EID: 34548129254     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2007.03.005     Document Type: Article

References (64)

1. Aaronson N.K., Ahmedzai S., Bergman B., Bullinger M., Cull A., Duez N.J., Filiberti A., Flechtner H., Fleishman S.B., de Haes J.C., et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J. Natl. Cancer Inst. 85 (1993) 365-376
2. Allen S.M., Shah A.C., Nezu A.M., Nezu C.M., Ciambrone D., Hogan J., and Mor V. A problem-solving approach to stress reduction among younger women with breast carcinoma. Cancer 94 (2002) 3089-3100
3. Andersen B.L. Psychological interventions for cancer patients to enhance the quality of life. J. Consult. Clin. Psychol. 60 (1992) 552-568
4. Andersen B.L. Biobehavioral outcomes following psychological interventions for cancer patients. J. Consult. Clin. Psychol. 70 (2002) 590-610
5. Andersen B.L., Farrar W.B., Golden-Kreutz D., Kutz L.A., MacCallum R., Courtney M.E., and Glaser R. Stress and immune responses after surgical treatment for regional breast cancer. J. Natl. Cancer Inst. 90 (1998) 30-36
6. Andersen B.L., Farrar W.B., Golden-Kreutz D.M., Glaser R., Emery C.F., Crespin T.R., Shapiro C.L., and Carson III W.E. Psychological, behavioral, and immune changes after a psychological intervention: a clinical trial. J. Clin. Oncol. 22 (2004) 3570-3580
7. Andersen B.L., Kiecolt-Glaser J.K., and Glaser R. A biobehavioral model of cancer stress and disease course. Amer. Psychol. 49 (1994) 389-404
8. Ayres A., Hoon P.W., Cotanch P.H., Franzoni J.B., Takayanagi S., and Matheny K.B. Influence of mood and adjustment to cancer on compliance with chemotherapy among breast cancer patients. J. Psychosom. Res. 38 (1994) 393-402
9. Bradley C.J., Neumark D., Luo Z., Bednarek H., and Schenk M. Employment outcomes of men treated for prostate cancer. J. Natl. Cancer Inst. 97 (2005) 958-965
10. Browne M.W., Cudeck R., Tateneni K., and Mels G. CEFA: Comprehensive Exploratory Factor Analysis. [Software] (1998), The Ohio State University, Columbus, OH
11. Cella D.F., Tulsky D.S., Gray G., Sarafian B., Linn E., Bonomi A., Silberman M., Yellen S.B., Winicour P., Brannon J., et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J. Clin. Oncol. 11 (1993) 570-579
12. Cohen J. Statistical Power Analysis for The Behavioral Sciences (1988), Academic Press, New York
13. Demissie S., Silliman R.A., and Lash T.L. Adjuvant tamoxifen: predictors of use, side effects, and discontinuation in older women. J. Clin. Oncol. 19 (2001) 322-328
14. de Wit R., van Dam F., Zandbelt L., van Buuren A., van der Heijden K., Leenhouts G., and Loonstra S. A pain education program for chronic cancer pain patients: follow-up results from a randomized controlled trial. Pain 73 (1997) 55-69
15. Dodd M.J. Efficacy of proactive information on self-care in chemotherapy patients. Patient Educ. Couns. 11 (1988) 215-225
16. Doorenbos A., Given B., Given C., and Verbitsky N. Physical functioning: effect of behavioral intervention for symptoms among individuals with cancer. Nurs. Res. 55 (2006) 161-171
17. Edgar L., Rosberger Z., and Collet J.P. Lessons learned: outcomes and methodology of a coping skills intervention trial comparing individual and group formats for patients with cancer. Int. J. Psychiatry Med. 31 (2001) 289-304
18. Edmonds C.V.I., Lockwood G.A., and Cunningham A.J. Psychological response to long term group therapy: a randomized trial with metastatic breast cancer patients. Psychooncology 8 (1999) 74-91
19. Fawzy F.I., Fawzy N.W., Hyun C.S., Elashoff R., et al. Malignant melanoma: effects of an early structured psychiatric intervention, coping, and affective state on recurrence and survival 6 years later. Arch. Gen. Psychiatry 50 (1993) 681-689
20. Forester B., Kornfeld D.S., and Fleiss J.L. Psychotherapy during radiotherapy: effects on emotional and physical distress. Am. J. Psychiatry 142 (1985) 22-27
21. Ganz P.A., Kwan L., Stanton A.L., Krupnick J.L., Rowland J.H., Meyerowitz B.E., Bower J.E., and Belin T.R. Quality of life at the end of primary treatment of breast cancer: first results from the moving beyond cancer randomized trial. J. Natl. Cancer Inst. 96 (2004) 376-387
22. Giesler R.B., Given B., Given C.W., Rawl S., Monahan P., Burns D., Azzouz F., Reuille K.M., Weinrich S., Koch M., and Champion V. Improving the quality of life of patients with prostate carcinoma. Cancer 104 (2005) 752-762
23. Girden E.R. ANOVA: Repeated Measures (1992), Sage, Newbury Park, CA
24. Golden-Kreutz D.M., Thornton L.M., Wells-Di Gregorio S., Frierson G.M., Jim H.S., Carpenter K.M., Shelby R.A., and Andersen B.L. Traumatic stress, perceived global stress, and life events: prospectively predicting quality of life in breast cancer patients. Health Psychol. 24 (2005) 288-296
25. Goodwin P.J., Black J.T., Bordeleau L.J., and Ganz P.A. Health-related quality-of-life measurement in randomized clinical trials in breast cancer-taking stock. J. Natl. Cancer Inst. 95 (2003) 263-281
26. Goodwin P.J., Leszcz M., Ennis M., Koopmans J., Vincent L., Guther H., Drysdale E., Hundleby M., Chochinov H.M., Navarro M., Speca M., and Hunter J. The effect of group psychosocial support on survival in metastatic breast cancer. N. Engl. J. Med. 345 (2001) 1719-1726
27. Helgeson V.S., Cohen S., Schulz R., and Yasko J. Education and peer discussion group interventions and adjustment to breast cancer. Arch. Gen. Psychiatry 56 (1999) 340-347
28. Horowitz M., Wilner N., and Alvarez W. Impact of Event Scale: a measure of subjective stress. Psychosom. Med. 41 (1979) 209-218
29. Janeway C. Immunobiology (2004), Garland Science, New York
30. Jim, H., Andersen, B., in press. Meaning in life mediates the relationship between social and physical functioning and distress in cancer survivors. Br. J. Health Psychol.
31. Johnson J.E., Nail L.M., Lauver D., King K.B., and Keys H. Reducing the negative impact of radiation therapy on functional status. Cancer 61 (1988) 46-51
32. Karnofsky D., and Burchenal J. The clinical evaluation of chemotherapeutic agents in cancer. In: Macleod C. (Ed). Evaluation of Chemotherapeutic Agents; Symposium held at the New York Academy of Medicine, March 25 and 26, 1948 (1949), Columbia University Press, New York 199-205
33. Kiecolt-Glaser J.K., McGuire L., Robles T.F., and Glaser R. Psychoneuroimmunology: psychological influences on immune function and health. J. Consult. Clin. Psychol. 70 (2002) 537-547
34. Lekander M., Furst C.J., Rostein S., Hursti T.J., and Fredrikson M. Immune effects of relaxation during chemotherapy for ovarian cancer. Psychother. Psychosom. 66 (1997) 185-191
35. Levin M., Mermelstein H., and Rigberg C. Factors associated with acceptance or rejection of recommendation for chemotherapy in a community cancer center. Cancer Nurs. 22 (1999) 246-250
36. Lutgendorf S.K., Johnson E.L., Cooper B., Anderson B., Sorosky J.I., Buller R.E., and Sood A.K. Vascular endothelial growth factor and social support in patients with ovarian carcinoma. Cancer 95 (2002) 808-815
37. Lyles J.N., Burish T.G., Krozely M.G., and Oldham R.K. Efficacy of relaxation training and guided imagery in reducing the aversiveness of cancer chemotherapy. J. Consult. Clin. Psych. 50 (1982) 509-524
38. MacVicar M.G., Winningham M.L., and Nickel J.L. Effects of aerobic interval training on cancer patients' functional capacity. Nurs. Res. 38 (1989) 348-351
39. Maguire P., Brooke M., Tait A., Thomas C., and Sellwood R. The effect of counseling on physical disability and social recovery after mastectomy. Clin. Oncol. 9 (1983) 319-324
40. Maltoni M., Caraceni A., Brunelli C., Broeckaert B., Christakis N., Eychmueller S., Glare P., Nabal M., Vigano A., Larkin P., De Conno F., Hanks G., and Kaasa S. Prognostic factors in advanced cancer patients: evidence-based clinical recommendations-a study by the Steering Committee of the European Association for Palliative Care. J. Clin. Oncol. 23 (2005) 6240-6248
41. McCorkle R., Benoliel J.Q., Donaldson G., Georgiadou F., Moinpour C., and Goodell B. A randomized clinical trial of home nursing care for lung cancer patients. Cancer 64 (1989) 1375-1382
42. McNair D., Lorr M., and Droppleman L. EITS Manual of the Profile of Mood States (1971), Educational and Industrial Testing Services, San Diego, CA
43. Miller G.E., and Cohen S. Psychological interventions and the immune system: a meta-analytic review and critique. Health Psychol. 20 (2001) 47-63
44. Mor V., Laliberte L., Morris J.N., and Wiemann M. The Karnofsky Performance Status scale. Cancer 53 (1984) 2002-2007
45. Mouridsen H., Gershanovich M., Sun Y., Perez-Carrion R., Boni C., Monnier A., Apffelstaedt J., Smith R., Sleeboom H.P., Jaenicke F., Pluzanska A., Dank M., Becquart D., Bapsy P.P., Salminen E., Snyder R., Chaudri-Ross H., Lang R., Wyld P., and Bhatnagar A. Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women: analysis of survival and update of efficacy from the International Letrozole Breast Cancer Group. J. Clin. Oncol. 21 (2003) 2101-2109
46. Mouridsen H., Sun Y., Gershanovich M., Perez-Carrion R., Becquart D., Chaudri-Ross H.A., and Lang R. Superiority of letrozole to tamoxifen in the first-line treatment of advanced breast cancer: evidence from metastatic subgroups and a test of functional ability. Oncologist 9 (2004) 489-496
47. Northouse L., Kershaw T., Mood D., and Schafenacker A. Effects of a family intervention on the quality of life of women with recurrent breast cancer and their family caregivers. Psychooncology 14 (2005) 478-491
48. Pelegri A., Calvo L., Anton A., Mayordomo J.I., Florian J., Vasquez S., Arcusa A., Martin-Richard M., Bayo J.L., Carrasco E., Virizuela J., and Virizuela J. Docetaxel/gemcitabine administered every other week as first-line treatment for metastatic breast cancer: final results of a phase II trial. Clin. Breast Cancer 6 (2005) 433-438
49. Potosky A.L., Harlan L.C., Stanford J.L., Gilliland F.D., Hamilton A.S., Albertsen P.C., Eley J.W., Liff J.M., Deapen D., Stephenson R.A., Legler J., Ferrans C.E., Talcott J.A., and Litwin M.S. Prostate cancer practice patterns and quality of life: the prostate cancer outcomes study. J. Natl. Cancer Inst. 91 (1999) 1719-1724
50. Quesnel C., Savard J., Simard S., Ivers H., and Morin C.M. Efficacy of cognitive-behavioral therapy for insomnia in women treated for nonmetastatic breast cancer. J. Consult. Clin. Psychol. 71 (2003) 189-200
51. Roscoe J.A., Morrow G.R., Hickok J.T., and Stern R.M. Nausea and vomiting remain a significant clinical problem: trends over time in controlling chemotherapy-induced nausea and vomiting in 1413 patients treated in community clinical practices. J. Pain Symptom Manage. 20 (2000) 113-121
52. Scheier M.F., Helgeson V.S., Schulz R., Colvin S., Berga S., Bridges M.W., Knapp J., Gerszten K., and Pappert W.S. Interventions to enhance physical and psychological functioning among younger women who are ending nonhormonal adjuvant treatment for early-stage breast cancer. J. Clin. Oncol. 23 (2005) 4298-4311
53. Shapiro C.L., and Recht A. Drug therapy: side effects of adjuvant treatment of breast cancer. N. Engl. J. Med. 344 (2001) 1997-2008
54. Spector P.E., and Jex S.M. Development of four self-report measures of job stressors and strain: Interpersonal Conflict at Work Scale, Organizational Constraints Scale, Quantitative Workload Inventory, and Physical Symptoms Inventory. J. Occup. Health. Psych. 3 (1998) 356-367
55. Spencer S.M., Lehman J.M., Wynings C., Arena P., Carver C.S., Antoni M.H., Derhagopian R.P., Ironson G., and Love N. Concerns about breast cancer and relations to psychosocial well-being in a multiethnic sample of early-stage patients. Health Psychol. 18 (1999) 159-168
56. Spiegel D., and Bloom J.R. Group therapy and hypnosis reduce metastatic breast cancer pain. Psychosom. Med. 45 (1983) 333-339
57. Spiegel D., Bloom J.R., Kraemer H.C., and Gottheil E. Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet 2 (1989) 888-891
58. Stanton A.L., Danoff-Burg S., Sworowski L.A., Collins C.A., Branstetter A.D., Rodriguez-Hanley A., Kirk S.B., and Austenfeld J.L. Randomized, controlled trial of written emotional expression and benefit finding in breast cancer patients. J. Clin. Oncol. 20 (2002) 4160-4168
59. Ware J., Snow K., and Kosinski M. SF-36 Health Survey: Manual and Interpretation Guide (2000), Quality Metric Incorporated, Lincoln, RI
60. Wimberly S.R., Carver C.S., Laurenceau J., Harris S.D., and Antoni M.H. Perceived partner reactions to diagnosis and treatment of breast cancer: impact on psychosocial and psychosexual adjustment. J. Consult. Clin. Psych. 73 (2005) 300-311
61. Yabroff K.R., Lawrence W.F., Claurser S., Davis W.W., and Brown M.L. Burden of illness in cancer survivors: findings from a population-based national sample. J. Natl. Cancer Inst. 96 (2004) 1322-1330
62. Yates P., Aranda S., Hargraves M., Mirolo B., Clavarino A., McLachlan S., and Skerman H. Randomized controlled trial of an educational intervention for managing fatigue in women receiving adjuvant chemotherapy for early-stage breast cancer. J. Clin. Oncol. 23 (2005) 6027-6036
63. Yates J.W., Chalmer B., and McKegney F.P. Evaluation of patients with advanced cancer using the Karnofsky performance status. Cancer 45 (1980) 2220-2224
64. Yates, J.W., McKegney, F.P., Kun, L.E., 1981. A comparative study of home nursing care of patients with advanced cancer. Proceedings of the National Conference on Human Values and Cancer. American Cancer Society, New York, pp. 207-218.